BiotechTube
Home/Amorphex Therapeutics/Robert Thompson
RT

Robert Thompson

President & CEO

Amorphex Therapeutics

Therapeutic Areas

OphthalmologyGlaucomaRetinal DiseasesMyopia

Amorphex Therapeutics Pipeline

DrugIndicationPhase
TODDD™ PlatformGlaucomaPre-clinical

Leadership Team at Amorphex Therapeutics

CL
Charles Leahy
Vice President, Clinical Affairs
View full Amorphex Therapeutics profile